Medicus Pharma Ltd

MDCXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

60.2M

on 2026-06-30, from 11.8M on 2024-12-31 10-Q ↗

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2025-12-30. 2 prospectus supplements filed under it since. S-3 ↗

$15.3M

Maxim Group, agreement of 2025-12-30. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

1.12M

Warrants of every class as tagged in the XBRL facts on 2024-12-31, exercise price $4.64. 10-K ↗

Cash

2.1 quarters

$15.2M on 2026-06-30 ÷ $7.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-05-29	Public offering	2,260,000	$3.10	$7.0M	424B4 ↗
2025-03-06	Private placement	not read	$2.80	$4.2M	8-K ↗

Also on file: up to $5.0M notes agreed 2025-05-02 8-K ↗ · $1.3M notes, 2025-06-17 8-K ↗